Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00140140
Status:
TERMINATED
Last Update Posted:
2019-11-26
First Post:
2005-08-30
Brief Title:
A Phase III Study of ABI-007 Abraxane Nab-Paclitaxeland Vinorelbine in Patients With Stage IV Metastatic Breast Cancer
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CA025
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None